Psyence Biomedical Ltd.
PBM
$0.5211
-$0.0122-2.29%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 163.57% | 0.00% | 0.00% | 21.17% | -54.65% |
| Total Receivables | -- | -- | 0.00% | 121.81% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 0.00% | 1,978.06% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 0.00% | 0.00% | -- |
| Total Current Assets | -- | -- | 0.00% | 68.42% | -- |
|
|
|||||
| Total Current Assets | -- | -- | 0.00% | 68.42% | -- |
| Net Property, Plant & Equipment | -- | -- | 0.00% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -- | -- | 0.00% | 69.24% | -- |
|
|
|||||
| Total Accounts Payable | -- | -- | 0.00% | -38.50% | -- |
| Total Accrued Expenses | -- | -- | 0.00% | -- | -- |
| Short-term Debt | -- | -- | 0.00% | 1,318.40% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 0.00% | -- | -- |
| Total Other Current Liabilities | -- | -- | 0.00% | -- | -- |
| Total Current Liabilities | -- | -- | 0.00% | 633.13% | -- |
|
|
|||||
| Total Current Liabilities | -- | -- | 0.00% | 633.13% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 0.00% | 1,318.40% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -- | -- | 0.00% | 633.13% | -- |
|
|
|||||
| Common Stock & APIC | -- | -- | 0.00% | 4,796.61% | -- |
| Retained Earnings | -- | -- | 0.00% | -- | -- |
| Treasury Stock & Other | -- | -- | 0.00% | -- | -- |
| Total Common Equity | 88.56% | 0.00% | 0.00% | -1,017.25% | -390.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 88.56% | 0.00% | 0.00% | -1,017.25% | -390.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 88.56% | 0.00% | 0.00% | -1,017.25% | -390.07% |
|
|
|||||